Newborns, especially premature infants, have immature liver enzyme systems, specifically UDP-glucuronyl transferase, which is responsible for the metabolism of chloramphenicol. This underdevelopment means that the drug's half-life is significantly prolonged, leading to accumulation and eventual toxicity. This physiological immaturity renders them particularly susceptible to gray baby syndrome when exposed to chloramphenicol.
